Drug Side Effects
Search
PANCREATIC CYSTADENOMA
PANCREATIC CYSTADENOMA
was reported 48 times
These drug classes are most commonly taken by patients reporting PANCREATIC CYSTADENOMA:
#
Drug
Count
0
Loop Diuretic [EPC]
13
1
Erythropoiesis-stimulating Agent [EPC]
11
2
alpha-Adrenergic Blocker [EPC]
11
3
beta-Adrenergic Blocker [EPC]
11
4
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
9
5
5-alpha Reductase Inhibitor [EPC]
7
6
Arteriolar Vasodilator [EPC]
7
7
Lipid-based Polyene Antifungal [EPC]
7
8
Polyene Antifungal [EPC]
7
9
Aldosterone Antagonist [EPC]
5
10
GLP-1 Receptor Agonist [EPC]
5
11
Aromatase Inhibitor [EPC]
4
12
Nonsteroidal Anti-inflammatory Drug [EPC]
4
13
Platelet Aggregation Inhibitor [EPC]
3
14
Aminosalicylate [EPC]
2
15
BCL-2 Inhibitor [EPC]
2
16
Corticosteroid [EPC]
2
17
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
2
18
Integrin Receptor Antagonist [EPC]
2
19
Proton Pump Inhibitor [EPC]
2
20
Tumor Necrosis Factor Blocker [EPC]
2
21
Anti-epileptic Agent [EPC]
1
22
Aromatic Amino Acid Decarboxylation Inhibitor [EPC]
1
23
Aromatic Amino Acid [EPC]
1
24
Calcium [EPC]
1
25
Cannabinoid [EPC]
1
26
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
1
27
Cytochrome P450 3A Inhibitor [EPC]
1
28
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
29
Dihydropyridine Calcium Channel Blocker [EPC]
1
30
Ergot Derivative [EPC]
1
31
Expectorant [EPC]
1
32
Histamine-2 Receptor Antagonist [EPC]
1
33
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
34
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
1
35
Interleukin-12 Antagonist [EPC]
1
36
Interleukin-23 Antagonist [EPC]
1
37
Janus Kinase Inhibitor [EPC]
1
38
Mood Stabilizer [EPC]
1
39
Phosphodiesterase 4 Inhibitor [EPC]
1
40
Protease Inhibitor [EPC]
1
41
Purine Antimetabolite [EPC]
1
42
Standardized Chemical Allergen [EPC]
1
43
Sulfonylurea [EPC]
1
44
Thiazide-like Diuretic [EPC]
1
45
Vitamin B12 [EPC]
1
46
Vitamin C [EPC]
1
47
Vitamin D [EPC]
1